Literature DB >> 25004991

Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review.

Sarah Ekeløf1, Jacob Rosenberg, Jan Skov Jensen, Ismail Gögenur.   

Abstract

Myocardial ischemia-reperfusion injury is a clinical challenge in interventional cardiology, and at the moment, no pharmacological agent is universally accepted in the prevention. In order to prevent inappropriate clinical trials, a potential pharmacological agent should be proved reproducibly effective in clinically relevant experimental studies before initiation of human studies. The closed-chest porcine model is a promising experimental model of ischemia-reperfusion injury. The purpose of this systematic review was to describe the pharmacological treatments evaluated in the closed-chest porcine model and discuss different aspects of the model for future use. The systematic review was performed according to the PRISMA guidelines.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25004991     DOI： 10.1007/s12265-014-9574-4

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


  63 in total

1.  Cyclosporine A, 2.5 mg/kg, does not reduce myocardial infarct size in a porcine model of ischemia and reperfusion.

Authors:  Lars O Karlsson; Niklas Bergh; Lars Grip
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011-05-13       Impact factor: 2.457

2.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

3.  In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk.

Authors:  Yoriyasu Suzuki; Jennifer K Lyons; Alan C Yeung; Fumiaki Ikeno
Journal:  Catheter Cardiovasc Interv       Date:  2008-01-01       Impact factor: 2.692

4.  Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.

Authors:  Jesper van der Pals; Sasha Koul; Patrik Andersson; Matthias Götberg; Joey F A Ubachs; Mikael Kanski; Håkan Arheden; Göran K Olivecrona; Bengt Larsson; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2010-09-27       Impact factor: 2.298

5.  Cardioprotection via modulation of calcium homeostasis by thiopental in hypoxia-reoxygenated neonatal rat cardiomyocytes.

Authors:  Hyun-Soo Kim; Ki-Chul Hwang; Wyun-Kon Park
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

Review 6.  Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.

Authors:  K A Reimer; R S Vander Heide; V J Richard
Journal:  Am J Cardiol       Date:  1993-12-16       Impact factor: 2.778

7.  Limitation of myocardial infarct size by superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig.

Authors:  U Näslund; S Häggmark; G Johansson; S L Marklund; S Reiz
Journal:  Circ Res       Date:  1990-05       Impact factor: 17.367

8.  Enzyme and immunohistochemical assessment of myocardial damage after ischaemia and reperfusion in a closed-chest pig model.

Authors:  L E Thornell; B Holmbom; A Eriksson; S Reiz; S Marklund; U Näslund
Journal:  Histochemistry       Date:  1992-12

9.  Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.

Authors:  Rabea Hinkel; Daniela Penzkofer; Stefanie Zühlke; Ariane Fischer; Wira Husada; Quan-Fu Xu; Elisabeth Baloch; Eva van Rooij; Andreas M Zeiher; Christian Kupatt; Stefanie Dimmeler
Journal:  Circulation       Date:  2013-07-29       Impact factor: 29.690

Review 10.  Signaling pathways in ischemic preconditioning.

Authors:  James M Downey; Amanda M Davis; Michael V Cohen
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214
View more
  2 in total

1.  The role of ADAMTS13 in acute myocardial infarction: cause or consequence?

Authors:  Elise S Eerenberg; Paul F A Teunissen; Bert-Jan van den Born; Joost C M Meijers; Maurits R Hollander; Matthijs Jansen; Ruben Tijssen; Jeroen A M Beliën; Peter M van de Ven; Mohamed F Aly; Otto Kamp; Hans W Niessen; Pieter Willem Kamphuisen; Marcel Levi; Niels van Royen
Journal:  Cardiovasc Res       Date:  2016-05-12       Impact factor: 10.787

2.  Models for preclinical studies in aging-related disorders: One is not for all.

Authors:  Gaetano Santulli; Consuelo Borras; Jean Bousquet; Laura Calzà; Antonio Cano; Maddalena Illario; Claudio Franceschi; Giuseppe Liotta; Marcello Maggio; William D Molloy; Nunzia Montuori; Rónán O'Caoimh; Francesc Orfila; Amelia P Rauter; Aurelia Santoro; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2016-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.